Engage Bio
Winter 2022 · Active
mRNA Immunotherapies to Eliminate Cancer
Location: Santa Clara, CA, US
Founded: 2021
Team size: 5
About
Engage Bio is developing mRNA immunotherapies to defeat cancer. Our founders have deep experience in immunotherapy development, including four drugs in the clinic, and in building mRNA therapeutics platforms. Our approach is to provide cancer cells with instructions to make and gradually release our drugs within solid tumors. This local therapy allows us to eliminate tumors while sparing healthy distant tissues.
Founders
Will OlsenFounder
Co-Founder & CEO of Engage Bio
Kathryn KwantFounder
Kathryn has 12 years of experience engineering proteins for improved properties. She spent 5 years as a key early scientist at Harpoon Therapeutics, where she developed bispecific immunotherapies and protease activated immunotherapies. She has helped develop multiple drugs that are currently in the clinic to treat various cancers and has multiple patents and patent applications.